Chronic diseases are considered among the leading causes of deaths worldwide. Additionally, management of such conditions have a significant impact on healthcare economy; in fact, costs associated with their treatment have increased at a rapid pace in recent years. For instance, in the US, the current expenditure on chronic diseases is close to USD 3.3 trillion, which accounts for nearly 90% of...

This section features an in-depth analysis of 260+ cell therapy and 190+ gene therapy developers that are anticipated to partner with bioassay contract service providers engaged in this domain, shortlisted based on several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on...

During our study, we were able to identify close to 500 players that are engaged in offering pharmaceutical contract manufacturing services. It is worth mentioning, most of the players (174) engaged in this domain offer contract manufacturing services for FDF / fill-finish operations, followed by those offering services for both API and FDF / fill-finish development (144). To Request for Sample...

Primary packaging, such as vials, syringes, and cartridges, and their affiliated closures, play a vital role in ensuring the stability, and sterility, and thereby, the overall quality, efficacy and safety of a drug product. Moreover, the packaging bears the product label, which provides information related to the drug and, in certain cases, dosing instructions.[1] Pharmaceutical packaging is...

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious op            timism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the...

Driven by several blockbuster products, a burgeoning pipeline and the need for dedicated expertise in the myriad of technical nuances associated with biomolecules, the biopharmaceutical contract manufacturing market has a lucrative future   Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharmaceutical Contract Biomanufacturing Market, (4th...

Driven by several blockbuster products, a burgeoning pipeline and the need for dedicated expertise in the myriad of technical nuances associated with biomolecules, the biopharmaceutical contract manufacturing market has a lucrative future   Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharmaceutical Contract Biomanufacturing Market, (4th...

Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer patients; several targeted therapies are being developed against squamous NSCLCs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Squamous Non-small Cell Lung Cancer Market,...

Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications   London   Roots Analysis has announced the addition of “Vascular Disrupting Agents Market, 2021-2030” report to its list of offerings.   Despite multiple cancer treatment options, there is an evident unmet need for...

Rising prevalence of skin disorders is expected to promote the adoption of light activated therapies, making it one of the relatively faster growing segments in this industry   Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal, 2021-2030“ report to its list of offerings.  ...